PharmaServ Express Inc., a Marikina-based healthcare logistics firm, is specializing in the cold-chain management of medicines and biological products. FoundedPharmaServ Express Inc., a Marikina-based healthcare logistics firm, is specializing in the cold-chain management of medicines and biological products. Founded

Marikina-based PharmaServ specializes in cold-chain logistics for vaccines, pharmaceuticals

2026/04/01 13:09
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

PharmaServ Express Inc., a Marikina-based healthcare logistics firm, is specializing in the cold-chain management of medicines and biological products.

Founded in 2015, it was established to address one of the most overlooked challenges in Philippine healthcare, which is access to safe, reliable, and temperature-compliant handling of medicines and biological products.

Unlike general logistics providers, it focuses exclusively on cold-chain management for life science products, the firm said.

This is to ensure that temperature-sensitive items such as vaccines and pharmaceuticals are handled under strict conditions throughout the supply chain.

During the COVID-19 pandemic, PharmaServ Express handled vaccines for the national government, meeting strict cold-chain requirements for storage and delivery.

“The company is driven by a single mandate: to provide solutions not just logistically, but in terms of access to safe healthcare products through a positive patient care experience,” PharmaServ Express said in a statement.

Its logistics network includes temperature-validated vehicles such as refrigerated trucks, vans, and motorcycles, supported by real-time GPS (global positioning system) and temperature monitoring systems.

Each shipment is accompanied by data-logging devices that record temperature conditions throughout the delivery process.

PharmaServ Express also said it combines technology with human oversight, with trained specialists supervising operations from dispatch to delivery.

Customer service teams are also available 24/7 to assist clients.

Last week, the company launched a consumer mobile application that allows patients to have medicines delivered to their homes under strict temperature control.

“What we have built for healthcare institutions, we are now making available to every Filipino home,” Andrian A. Perez, president of PharmaServ Express Inc., said in a statement.

“This app is our answer to problems that have gone unaddressed for too long—long lines at the pharmacy, incomplete medicines, and drug products losing their potency before they reach the patient,” he added.

Through the PharmaServ Express app, patients can have prescriptions, medical devices, and personal care products delivered from their preferred drugstore in Metro Manila and nearby areas, with expert guidance from online pharmacists.

Each order is packed in temperature-controlled boxes with data loggers to ensure quality throughout delivery.

Looking ahead, the platform will also launch a Diagnostic Test Booking and Scheduling feature this year.

PharmaServ Expres operates two facilities, with the main operations center in Marikina City and a cold storage warehouse in Pasig City.

According to Future Market Report, an India-based commercial market research provider, the global pharmacy delivery app market was estimated to value at US$13.2 billion in 2024 and is projected to reach US$28.05 billion by 2033.

The market has compound annual growth rate (CAGR) of 9.6% starting 2025. — Edg Adrian A. Eva

Market Opportunity
Based Logo
Based Price(BASED)
$0.06429
$0.06429$0.06429
-5.17%
USD
Based (BASED) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!